These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

818 related items for PubMed ID: 18096270

  • 41. HPMC capsules: current status and future prospects.
    Al-Tabakha MM.
    J Pharm Pharm Sci; 2010; 13(3):428-42. PubMed ID: 21092714
    [Abstract] [Full Text] [Related]

  • 42. Characteristics of a novel phospholipid-based depot injectable technology for poorly water-soluble drugs.
    Tiemessen H, van Hoogevest P, Leigh ML.
    Eur J Pharm Biopharm; 2004 Nov; 58(3):587-93. PubMed ID: 15451533
    [Abstract] [Full Text] [Related]

  • 43. [Natural biopolymers as excipients in medicinal product dosage form. Part I. Soft gelatin capsules as a modern and elegant pharmaceutical dosage form].
    Dobrzyński ŁJ, Zgoda MM.
    Polim Med; 2010 Nov; 40(2):11-9. PubMed ID: 20649085
    [Abstract] [Full Text] [Related]

  • 44. Liquid Filled Hard Shell Capsules: Current Drug Delivery Influencing Pharmaceutical Technology.
    Nirale P, Arora S, Solanki A, Bhat J, Singh RK, Yadav KS.
    Curr Drug Deliv; 2022 Nov; 19(2):238-249. PubMed ID: 33645480
    [Abstract] [Full Text] [Related]

  • 45. Oral lipid-based formulations.
    Hauss DJ.
    Adv Drug Deliv Rev; 2007 Jul 30; 59(7):667-76. PubMed ID: 17618704
    [Abstract] [Full Text] [Related]

  • 46. Ease of oral administration and owner-perceived acceptability of triglyceride oil, dissolving thin film strip, and gelatin capsule formulations to healthy cats.
    Traas AM, Fleck T, Ellings A, Mahabir S, Stuebner K, Brown DC, Durso D, DiGregorio M, Bode L, Kievit KI, McCall R.
    Am J Vet Res; 2010 Jun 30; 71(6):610-4. PubMed ID: 20513174
    [Abstract] [Full Text] [Related]

  • 47. Comparison of high-resolution ultrasonic resonator technology and Raman spectroscopy as novel process analytical tools for drug quantification in self-emulsifying drug delivery systems.
    Stillhart C, Kuentz M.
    J Pharm Biomed Anal; 2012 Feb 05; 59():29-37. PubMed ID: 22079118
    [Abstract] [Full Text] [Related]

  • 48. Evaluating the sensitivity, reproducibility and flexibility of a method to test hard shell capsules intended for use in dry powder inhalers.
    Chong RH, Jones BE, Díez F, Birchall JC, Coulman SA.
    Int J Pharm; 2016 Mar 16; 500(1-2):316-25. PubMed ID: 26806464
    [Abstract] [Full Text] [Related]

  • 49. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
    Constantinides PP, Chaubal MV, Shorr R.
    Adv Drug Deliv Rev; 2008 Mar 17; 60(6):757-67. PubMed ID: 18096269
    [Abstract] [Full Text] [Related]

  • 50. Influence of rheological behaviour of particulate/polymer dispersions on liquid-filling characteristics for hard gelatin capsules.
    Kattige A, Rowley G.
    Int J Pharm; 2006 Jun 19; 316(1-2):74-85. PubMed ID: 16567071
    [Abstract] [Full Text] [Related]

  • 51. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
    Al-Tabakha MM, Arida AI, Fahelelbom KM, Sadek B, Saeed DA, Abu Jarad RA, Jawadi J.
    Drug Dev Ind Pharm; 2015 Jun 19; 41(10):1726-37. PubMed ID: 25586554
    [Abstract] [Full Text] [Related]

  • 52. The influence of polymorphism on the manufacturability and in vitro dissolution of sulindac-containing hard gelatin capsules.
    Guadalupe Sánchez-González E, Yépez-Mulia L, Jesús Hernández-Abad V, Jung Cook H.
    Pharm Dev Technol; 2015 May 19; 20(3):306-13. PubMed ID: 24417644
    [Abstract] [Full Text] [Related]

  • 53. Stabilization of hard gelatin capsule shells filled with polyethylene glycol matrices.
    Stein D, Bindra DS.
    Pharm Dev Technol; 2007 May 19; 12(1):71-7. PubMed ID: 17484146
    [Abstract] [Full Text] [Related]

  • 54. Potentials and challenges in self-nanoemulsifying drug delivery systems.
    Khan AW, Kotta S, Ansari SH, Sharma RK, Ali J.
    Expert Opin Drug Deliv; 2012 Oct 19; 9(10):1305-17. PubMed ID: 22954323
    [Abstract] [Full Text] [Related]

  • 55. Method for screening of solid dispersion formulations of low-solubility compounds--miniaturization and automation of solvent casting and dissolution testing.
    Shanbhag A, Rabel S, Nauka E, Casadevall G, Shivanand P, Eichenbaum G, Mansky P.
    Int J Pharm; 2008 Mar 03; 351(1-2):209-18. PubMed ID: 18054181
    [Abstract] [Full Text] [Related]

  • 56. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A, De Beer T, Remon JP, Baeyens W, Foreman P, Vervaet C.
    Eur J Pharm Biopharm; 2008 Sep 03; 70(1):302-12. PubMed ID: 18579353
    [Abstract] [Full Text] [Related]

  • 57. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system.
    Pouton CW.
    Eur J Pharm Sci; 2006 Nov 03; 29(3-4):278-87. PubMed ID: 16815001
    [Abstract] [Full Text] [Related]

  • 58. 50years of oral lipid-based formulations: Provenance, progress and future perspectives.
    Feeney OM, Crum MF, McEvoy CL, Trevaskis NL, Williams HD, Pouton CW, Charman WN, Bergström CAS, Porter CJH.
    Adv Drug Deliv Rev; 2016 Jun 01; 101():167-194. PubMed ID: 27089810
    [Abstract] [Full Text] [Related]

  • 59. Frosta: a new technology for making fast-melting tablets.
    Jeong SH, Fu Y, Park K.
    Expert Opin Drug Deliv; 2005 Nov 01; 2(6):1107-16. PubMed ID: 16296813
    [Abstract] [Full Text] [Related]

  • 60. Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products.
    Strauch S, Jantratid E, Dressman JB.
    J Pharm Pharmacol; 2009 Mar 01; 61(3):331-7. PubMed ID: 19222905
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.